Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
Launched by UNIVERSITEIT ANTWERPEN · Jul 22, 2025
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using Kinesio tape—an elastic therapeutic tape—can help women who have ongoing swelling (called oedema) in the breast or chest area after breast cancer treatment. The researchers want to find out if adding Kinesio taping to the usual care, which includes special therapy to reduce swelling, can better reduce pain and swelling, and improve overall quality of life.
Women eligible for this study are those who had breast cancer treatment and have had breast or chest swelling lasting more than six months after finishing radiotherapy. To join, they must show certain signs of swelling confirmed by both questionnaires and physical measurements. Participants will be randomly placed into two groups: one group will receive standard swelling therapy, while the other will get the same therapy plus Kinesio taping. Treatments will happen twice a week for four weeks, followed by check-ups over six months to see how well the treatments worked. This study will help us understand if Kinesio taping is a useful addition to care for women dealing with long-term swelling after breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients previously treated for breast cancer.
- • Suffering from persistent (\>6 months) breast and/or truncal oedema, established at least six months after completion of radiotherapy.
- * Objective measurements:
- • BrEQ score ≥9.
- * PWC (LymphScanner) showing at least one of the following:
- • Truncal oedema: ratio ≥ 1.32.
- • Breast oedema: ratio ≥ 1.28.
- • Local PWC of 52.90%.
- * Clinical evaluation:
- * At least one positive sign of breast and/or truncal oedema such as:
- • Visual swelling compared with the contralateral side.
- • Visible imprint of the bra on the skin.
- • Peau d'orange appearance on the breast.
- Exclusion Criteria:
- • Presence of skin infections or wounds of the breast/truncal region at the time of inclusion making it impossible to apply kinesio tape.
- • Age under 18 years.
- • Not able to read and understand Dutch language.
- • Having received mastectomy.
- • Metastatic breast cancer.
About Universiteit Antwerpen
The University of Antwerp is a leading research institution based in Belgium, renowned for its commitment to advancing knowledge and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to improve healthcare outcomes and enhance understanding of complex medical conditions. The University of Antwerp's dedicated research teams leverage cutting-edge methodologies and state-of-the-art facilities to conduct rigorous studies, ensuring adherence to the highest ethical standards and regulatory requirements. Through its clinical trial initiatives, the university strives to translate research findings into practical applications that benefit patients and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kortrijk, , Belgium
Gent, , Belgium
Antwerp, , Belgium
Antwerpen, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported